Address: Donau-City-Strasse 6, 1220 Vienna / Austria
Tel: +43 1 403 38 05
Web: http://www.assigngroup.com/
The Assign Group is a fully integrated bio and pharmaceutical service provider. Our clients benefit from harmonized interfaces and SOPs from various functions necessary in pharmaceutical development.
We conduct clinical development in currently 30 countries with 200 employees. Through Assign Resourcing we provide clincial research professionals.
We pride ourselves with flexible and experienced teams.
We work according to your client´s time schedule and requirements.
Through our offices in Germany (2), Austria (3), Hungary (1), UK (1), Netherlands (1), Belgium (1) and
Poland (2), our qualified professionals are in close proximity to our clients, which helps to reduce project management time and to ensure timely execution of deliverables.
We have extensive experience in managing clinical trials in all continents, with a particular expertise in Eastern and Western Europe.
We are a “One-Stop-Shop” for all Clinical Development needs.
We have implemented highest quality and ethical standards.
Toxicology and Preclinical
Clinical Development Planning (ID, IMPD, Scientific Advice)
Project Management of Clinical Studies
Regulatory contacts (EC, CA submissions)
Clinical Monitoring
Pharmacovigilance (Coding: MedDRA, WHO-DD, ATC)
Data Management (Integrated Oracle EDC Systems)
Biostatistics
IMP Handling (QP Releases, Labeling, Import Export Distribution, Primary Packaging)
Central and Analytical Laboratory
Medical Writing (Study Protocols, Study Reports)
Quality Management (Audits)
Assign Group started in 2002 as a small local CRO company founded in Austria; monitoring and doing minor project management only. Why was Austria chosen as the headquarters? First, it…
Barbara Fritsche-Surchat, general manager of Servier Austria, a leading innovative French company looking to bolster its global oncology presence, provides an in-depth analysis of the balancing act between pricing and…
Martin Spatz, country manager of QuintilesIMS Austria, the global leader in healthcare market research, discusses the diverse range of services they provide to the two separate entities of the of…
Rudolf Wessely, CEO and founder of Gynial, the Austrian leader in oral contraceptives, elaborates on the company’s incredibly fast market penetration since 2007 and explains his expertise in the contraceptive…
Bernhard Wittmann, managing director of Sigmapharm and MoNo, discusses the company’s product portfolio and the diverse tailored services for their partners. Furthermore, he provides an in-depth look into MoNo’s new…
Martin Tiani, CEO of Tiani Spirit, the global leader in Integrating the Healthcare Enterprise (IHE), discusses the importance of interoperability within electronic health information exchange (HIE) and the challenges e-health faces, especially…
Dr. Dietmar Katinger, CEO of Polymun, an Austrian R&D and contract manufacturing company, discusses the challenges CMO companies face within the Austrian market and increasing industry regulations. He also provides…
Like a family recipe that has been refined and perfected over countless generations, Austria has developed a reputation as the quintessential clinical trials destination; a perfect combination of world-class academia,…
Dr. Kurt Zatloukal, national node director of the Bio-Banking and Bio-Molecular Resources Research Infrastructure of Austria (BBMRI Austria), discusses the challenges of collaboration between the private and academic pharmaceutical sectors…
Dr. Daniel Wallerstorfer, CEO and founder of Novogenia, a vibrant Austrian genetics company, discusses founding his own company and the innovative services Novogenia provides to ensure genetics are a staple…
Günther Aschenbrenner, managing director of Théa Austria, a specialist French ophthalmology company, discusses the development of the company’s Austrian office since 2011 and how a strong portfolio acquired by Théa…
Daniela Homan, executive director of AmCham Austria, the representative and advocating voice of US companies in Austria, provides an in-depth analysis of the strategies being employed by the chamber and…
Karl Peter Schwarz, general manager of the Austrian affiliate of LEO Pharma, an ambitious Danish company leading the way in innovative dermatology treatments, provides an in-depth look into how global…
See our Cookie Privacy Policy Here
